Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 9.03 USD 4.27% Market Closed
Market Cap: 475.2m USD
Have any thoughts about
Zevra Therapeutics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Zevra Therapeutics Inc

Current Assets 60.9m
Cash & Short-Term Investments 49.3m
Receivables 8.9m
Other Current Assets 2.7m
Non-Current Assets 83.5m
PP&E 1.6m
Intangibles 70.9m
Other Non-Current Assets 11.1m
Current Liabilities 30.4m
Accounts Payable 20.5m
Accrued Liabilities 596k
Other Current Liabilities 9.4m
Non-Current Liabilities 81.5m
Long-Term Debt 58.3m
Other Non-Current Liabilities 23.2m

Balance Sheet
Zevra Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
10
32
17
11
18
3
4
112
66
43
Cash Equivalents
10
32
17
11
18
3
4
112
66
43
Short-Term Investments
0
19
51
31
3
0
0
0
17
25
Total Receivables
0
0
5
2
0
2
3
2
8
17
Accounts Receivables
0
0
5
2
0
2
2
1
7
16
Other Receivables
0
0
0
0
0
0
0
0
1
1
Other Current Assets
0
3
2
3
2
2
2
1
2
2
Total Current Assets
10
54
74
47
24
7
8
115
93
87
PP&E Net
0
0
2
2
2
3
2
2
2
2
PP&E Gross
0
0
2
0
2
3
2
2
2
2
Accumulated Depreciation
0
0
1
0
1
0
2
2
1
2
Intangible Assets
0
0
0
0
0
0
0
0
0
69
Goodwill
0
0
0
0
0
0
0
0
0
5
Long-Term Investments
0
0
8
3
0
0
0
15
20
0
Other Long-Term Assets
3
0
0
0
1
1
0
0
1
10
Other Assets
0
0
0
0
0
0
0
0
0
5
Total Assets
14
N/A
55
+299%
85
+55%
53
-38%
27
-49%
11
-61%
11
+7%
133
+1 087%
116
-13%
172
+49%
Liabilities
Accounts Payable
2
5
1
8
4
5
1
1
4
14
Accrued Liabilities
2
0
6
0
5
0
6
3
3
15
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
3
0
4
4
0
1
0
5
38
Other Current Liabilities
0
0
0
0
0
0
0
1
0
7
Total Current Liabilities
4
8
7
12
12
5
8
4
12
74
Long-Term Debt
18
19
91
90
79
78
68
0
13
5
Other Liabilities
16
38
6
9
3
2
2
2
5
32
Total Liabilities
38
N/A
65
+70%
104
+60%
110
+6%
93
-15%
85
-9%
78
-9%
6
-93%
30
+412%
110
+272%
Equity
Common Stock
24
0
0
0
0
0
0
0
0
0
Retained Earnings
50
105
121
165
221
246
259
267
309
400
Additional Paid In Capital
2
95
103
107
155
171
192
397
402
473
Treasury Stock
0
0
0
0
0
0
0
3
8
11
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
24
N/A
10
+58%
19
-85%
58
-207%
67
-16%
75
-12%
66
+11%
127
N/A
86
-32%
62
-28%
Total Liabilities & Equity
14
N/A
55
+299%
85
+55%
53
-38%
27
-49%
11
-61%
11
+7%
133
+1 087%
116
-13%
172
+49%
Shares Outstanding
Common Shares Outstanding
0
1
1
1
2
2
5
35
35
42
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Discover More